Pluri (PLUR) Retained Earnings (2011 - 2025)
Pluri (PLUR) reported Retained Earnings of -$455.4 million for Q4 2025, down 6.09% year-over-year from -$485.0 million in Q4 2024, and down 1.46% quarter-over-quarter from -$448.9 million in Q3 2025.
Pluri (PLUR) Retained Earnings (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Retained Earnings data on file, last reported at -$455.4 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$455.4 million, down 6.09% year-over-year; the trailing twelve-month figure through Dec 2025 was -$455.4 million (down 6.09% YoY), and the FY2025 annual result was -$443.1 million, down 5.37% from the prior year.
- Retained Earnings fell to -$455.4 million in Q4 2025 per PLUR's latest filing, from -$448.9 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$315.5 million in Q1 2021 and troughed at -$455.4 million in Q4 2025.
- A 5-year average of -$395.8 million and a median of -$402.1 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings slipped 18.3% in 2021, then retreated 4.85% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$352.4 million in 2021, then slipped by 9.4% to -$385.5 million in 2022, then declined by 6.21% to -$409.4 million in 2023, then retreated by 4.85% to -$429.3 million in 2024, then fell by 6.09% to -$455.4 million in 2025.
- Business Quant data shows PLUR's Retained Earnings at -$455.4 million in Q4 2025, -$448.9 million in Q3 2025, and -$443.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -455.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -455.45 Mn |
| Sep 30, 2025 | -448.91 Mn |
| Jun 30, 2025 | -443.06 Mn |
| Mar 31, 2025 | -435.46 Mn |
| Dec 31, 2024 | -429.31 Mn |
| Sep 30, 2024 | -426.35 Mn |
| Jun 30, 2024 | -420.47 Mn |
| Mar 31, 2024 | -414.74 Mn |
| Dec 31, 2023 | -409.45 Mn |
| Sep 30, 2023 | -404.55 Mn |
| Jun 30, 2023 | -399.58 Mn |
| Mar 31, 2023 | -393.13 Mn |
| Dec 31, 2022 | -385.50 Mn |
| Sep 30, 2022 | -377.38 Mn |
| Jun 30, 2022 | -371.26 Mn |
| Mar 31, 2022 | -362.26 Mn |
| Dec 31, 2021 | -352.39 Mn |
| Sep 30, 2021 | -341.45 Mn |
| Jun 30, 2021 | -330.02 Mn |
| Mar 31, 2021 | -315.45 Mn |